BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37909989)

  • 1. Non-thermal Acoustic Enhancement of Chemotherapeutic Effects of Cisplatin on Xenografted Cervical Cancer in Mice.
    Yoo SS; Katsarakes P; Gashi J; Kim E; Kim HC; Böhlke M
    Anticancer Res; 2023 Nov; 43(11):4793-4800. PubMed ID: 37909989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focused ultrasound enhances the anesthetic effects of topical lidocaine in rats.
    Kim HC; Lee W; Böhlke M; Yoon K; Yoo SS
    BMC Anesthesiol; 2021 May; 21(1):158. PubMed ID: 34020595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high-intensity focused ultrasound in combination with cisplatin using a Xenograft model of cervical cancer.
    Lee YY; Cho YJ; Choi JJ; Choi CH; Kim TJ; Kim BG; Bae DS; Kim YS; Lee JW
    Anticancer Res; 2012 Dec; 32(12):5285-9. PubMed ID: 23225428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile.
    Federico C; Sun J; Muz B; Alhallak K; Cosper PF; Muhammad N; Jeske A; Hinger A; Markovina S; Grigsby P; Schwarz JK; Azab AK
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1483-1494. PubMed ID: 33253820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Developed MRI-Guided Focused Ultrasound System in 7 T Small Animal MRI and Proof-of-Concept in a Prostate Cancer Xenograft Model to Improve Radiation Therapy.
    Zhang X; Greiser S; Roy U; Lange F; van Gorkum R; Fournelle M; Speicher D; Tretbar S; Melzer A; Landgraf L
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations.
    Qiu F; Zhao X
    J BUON; 2018; 23(1):117-123. PubMed ID: 29552770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM; Oliver PG; Zhou T; Wang W; Alvarez RD; Grizzle WE; Buchsbaum DJ
    Gynecol Oncol; 2006 Apr; 101(1):46-54. PubMed ID: 16271751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial focused ultrasound-mediated unbinding of phenytoin from plasma proteins for suppression of chronic temporal lobe epilepsy in a rodent model.
    Kim E; Kim HC; Van Reet J; Böhlke M; Yoo SS; Lee W
    Sci Rep; 2023 Mar; 13(1):4128. PubMed ID: 36914775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice.
    Dou YN; Zheng J; Foltz WD; Weersink R; Chaudary N; Jaffray DA; Allen C
    J Control Release; 2014 Mar; 178():69-78. PubMed ID: 24440663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment.
    Ma Y; Han J; Jiang J; Zheng Z; Tan Y; Liu C; Zhao Y
    Life Sci; 2020 Dec; 262():118565. PubMed ID: 33038371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
    Yokoyama Y; Xin B; Shigeto T; Mizunuma H
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers.
    Yamaguchi K; Matsumoto Y; Suzuki R; Nishida H; Omata D; Inaba H; Kukita A; Tanikawa M; Sone K; Oda K; Osuga Y; Maruyama K; Fujii T
    Cancer Sci; 2021 Jun; 112(6):2493-2503. PubMed ID: 33793049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines.
    Miyamoto Y; Nakagawa S; Wada-Hiraike O; Seiki T; Tanikawa M; Hiraike H; Sone K; Nagasaka K; Oda K; Kawana K; Nakagawa K; Fujii T; Yano T; Kozuma S; Taketani Y
    Oncol Rep; 2013 Jan; 29(1):51-7. PubMed ID: 23064281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.
    Trejo-Becerril C; Pérez-Cárdenas E; Treviño-Cuevas H; Taja-Chayeb L; García-López P; Segura-Pacheco B; Chávez-Blanco A; Lizano-Soberon M; González-Fierro A; Mariscal I; Wegman-Ostrosky T; Dueñas-González A
    Int J Cancer; 2003 May; 104(6):663-8. PubMed ID: 12640671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts.
    Chaudary N; Pintilie M; Hedley D; Hill RP; Milosevic M; Mackay H
    Br J Cancer; 2017 Jan; 116(1):50-57. PubMed ID: 27875522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic Research of the Adenovirus-mediated
    Wu XL; Guo T; Cai HW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):34-38. PubMed ID: 29737086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
    Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
    Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.